The bitter truth about cancer disease is that a majority of victims could be saved with an early and precise diagnosis. Screening for cancer at an early stage can put before a host of treatment options. The Oncology Test Options at Anderson Diagnostics are extensive and designed to answer clinical questions pertaining to the disease. Effective testing can help in risk prediction, prognosis, monitoring, therapy, and pharmacogenomics. Based on the disease indications, the tests are conducted, and our menu is extensive including FISH, immunohistochemistry, flow cytometry and molecular techniques. Apart from these, there is a host of specimen types like cells, peripheral fluids, and cells.
Molecular technique screening for specific tumor mutations, gene expression and chromosomal alternation embrace FISH, DNA Sequencing and PCR. Also, find an elaborate immunohistochemistry listing facilitates protein expression test at a cellular level. Our latest esoteric tumor markers are alpha fetoprotein L3 percent and DCP to test hepatocellular carcinoma. It also includes Squamous Cell Carcinoma Antigen (SCC) for lung cancer, Cytokeration 19 fragment (CYFRA 21-1) and hepatocellular carcinoma, soluble mesothelin-related peptides (SMRPs) for malignant mesothelioma Septin 9 methylated DNA for blood-based colorectal cancer screening and inhibin B, particularly for ovarian granulose cell tumors.
The success of any treatment process lies in early detection and intervention, the same holds good for cancer. Anderson Diagnostics helps in identifying the treatment plan with timely screening for cancer. For cervical cancer, breast cancer, and prostate cancer, screening methods like PAP Smear, Mammography or PSA are available. For other types of cancers, the diagnosis includes blood tests, liquid biopsy, biopsy, PET, CT scan, MRI scan and X Ray. Gone are the days of conventional screening process like ultrasound and conventional mammography. The best results can be achieved with digital mammography as the suspicious lesions are identified accurately. Image-based biopsies help precise identification and cut negative rates.
Menu of Diagnostic Services
Skyra 3T MRI is a customised technology facilitating optimised scans based on the condition of the patient and clinical questions. The benefits of Skyra 3T MRI scan includes a higher signal to noise ratio, high resolution, faster scan, 3D data, exploring blood magnetic properties for superior image quality.
Automated Breast Volume Scanner (ABVS)
ABVS is the latest in breast cancer detection especially for patients with dense breast tissue. It allows for elaborate and concise images. Tumors hide between the dense breast tissues making it difficult to screen. With ABVS, multi use ultrasound system this concern is put to rest as high resolution, complete and volume datasets are made available in just a few minutes.
Breast cancer risks are prevalent in both men and women. Mammography helps in early detection and treatment. In digital mammography, safe and precise images of the breast in different directions are taken on the film mammogram. The images are then enlarged for better representation. Even lumps as small as 5 mm in size or less can be detected by digital mammography, and it requires less X ray dosage.
PET CT scan
This type of scan offers accurate anatomic localisation that was not available with exclusive PET imaging. Conventional PET machines are being abandoned with latest PET CET taking over the reins. It is a combination of two devices in one and comes with price point advantage. The data source is very powerful and helps in precise diagnosis. The diagnosis is completely safe and helps make the right decision. Moreover, it prevents unnecessary surgery. The test can tell whether the tumor is malignant or benign. The best part of the screening test is its ability to show if the cancer has spread to other parts of the body. The disease can be detected effectively before it shows up in other tests. It is a great tool assisting in radiation therapy.